Advancing pharmacotherapy for treating Huntington’s disease: a review of the existing literature
出版年份 2015 全文链接
标题
Advancing pharmacotherapy for treating Huntington’s disease: a review of the existing literature
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 17, Issue 1, Pages 41-52
出版商
Informa Healthcare
发表日期
2015-11-05
DOI
10.1517/14656566.2016.1109630
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sleep deficits but no metabolic deficits in premanifest Huntington's disease
- (2015) Alpar S. Lazar et al. ANNALS OF NEUROLOGY
- Dopamine and Huntington’s disease
- (2015) Laetitia C Schwab et al. Expert Review of Neurotherapeutics
- Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial
- (2015) Joaquim J. Ferreira et al. MOVEMENT DISORDERS
- Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
- (2015) Kristoffer Sahlholm et al. PSYCHOPHARMACOLOGY
- Dopamine and Huntington’s disease
- (2015) Laetitia C Schwab et al. Expert Review of Neurotherapeutics
- Apathy Is Not Depression in Huntington’s Disease
- (2014) Paul Naarding et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease
- (2014) Deb A. Kegelmeyer et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study
- (2014) Jane S Paulsen et al. LANCET NEUROLOGY
- Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records
- (2013) Stephen JW Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Results of the citalopram to enhance cognition in Huntington disease trial
- (2013) Leigh J. Beglinger et al. MOVEMENT DISORDERS
- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Off label use of lithium in the treatment of Huntington′s disease: A case series
- (2013) Vijay Danivas et al. Indian Journal of Psychiatry
- Unintended effects of orphan product designation for rare neurological diseases
- (2012) Sinéad M. Murphy et al. ANNALS OF NEUROLOGY
- Huntington’s disease from the patient, caregiver and physician’s perspectives: three sides of the same coin?
- (2012) Krzysztof Banaszkiewicz et al. JOURNAL OF NEURAL TRANSMISSION
- Tetrabenazine
- (2011) Lesley J. Scott CNS DRUGS
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Suicidal Behavior in Prodromal Huntington Disease
- (2011) Jess G. Fiedorowicz et al. Neurodegenerative Diseases
- Weight gain and ghrelin level after olanzapine monotherapy
- (2011) Vincent Chin-Hung Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
- (2010) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Neurocognitive signs in prodromal Huntington disease.
- (2010) Julie C. Stout et al. NEUROPSYCHOLOGY
- Earliest functional declines in Huntington disease
- (2010) Leigh J. Beglinger et al. PSYCHIATRY RESEARCH
- Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
- (2009) Samuel Frank BMC Neurology
- Combating depression in Huntingtonʼs disease: effective antidepressive treatment with venlafaxine XR
- (2009) Anna K. Holl et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease
- (2009) Leigh J. Beglinger et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A pilot study using nabilone for symptomatic treatment in Huntington's disease
- (2009) Adrienne Curtis et al. MOVEMENT DISORDERS
- A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease
- (2008) Samuel Frank et al. CLINICAL NEUROPHARMACOLOGY
- The Long-term Effect of Tetrabenazine in the Management of Huntington Disease
- (2008) Alfonso Fasano et al. CLINICAL NEUROPHARMACOLOGY
- The metabolic profile of early Huntington's disease- a combined human and transgenic mouse study
- (2008) Anna O.G. Goodman et al. EXPERIMENTAL NEUROLOGY
- Hand tapping: A simple, reproducible, objective marker of motor dysfunction in Huntington’s disease
- (2008) A. W. Michell et al. JOURNAL OF NEUROLOGY
- Patient and caregiver quality of life in Huntington's disease
- (2008) Rebecca E. Ready et al. MOVEMENT DISORDERS
- A Europe-wide assessment of current medication choices in Huntington's disease
- (2008) Josef Priller et al. MOVEMENT DISORDERS
- Health-related quality of life in Huntington's disease: Which factors matter most?
- (2008) Aileen K. Ho et al. MOVEMENT DISORDERS
- Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
- (2008) Livia Brusa et al. MOVEMENT DISORDERS
- The effects of modafinil on mood and cognition in Huntington’s disease
- (2008) Andrew D. Blackwell et al. PSYCHOPHARMACOLOGY
- Lamotrigine in motor and mood symptoms of Huntington's disease
- (2008) Yu-Chih Shen WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search